The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review
Open accessAbstract
Background: Mammographic screening alone will miss a certain fraction of malignancies, as evidenced by retrospective reviews of mammograms following a subsequent screening. Mammographic breast density is a marker for increased breast cancer risk and is associated with a higher risk of interval breast cancer, i.e. cancer detected between screening tests. The purpose of this review is to estimate risks and benefits of supplemental breast ultrasound in women with negative mammographic screening with dense breast tissue. Methods: A systematic search and review of studies involving mammography and breast ultrasound for screening of breast cancer was conducted. The search was performed for the period 1/2000-8/2008 within the data source of PubMed, DARE, and Cochrane databases. Inclusion and exclusion criteria were determined prospectively, and the Oxford evidence classification system for diagnostic studies was used for evidence level. The parameters biopsy rate, positive predictive value (PPV) for biopsy, cancer yield for breast ultrasound alone, and carcinoma detection rate by breast density were extracted or constructed. Results: The systematic search identified no randomized controlled trials or systematic reviews, six cohort studies of intermediate level of evidence (3b) were found. Only two of the studies included adequate follow-up of subjects with negative or benign findings. Supplemental breast ultrasound after negative mammographic screening permitted diagnosis of primarily invasive carcinomas in 0.32% of women in breast density type categories 2-4 of the American College of Radiology (ACR); mean tumor size for those identified was 9.9 mm, 90% with negative lymph node status. Most detected cancers occurred in mammographically dense breast ACR types 3 and 4. Biopsy rates were in the range 2.3%-4.7%, with PPV of 8.4-13.7% for those biopsied due to positive ultrasound, or about one third of the PPV of biopsies due to mammography. Limitations: The study populations included wide age ranges, and the application to women age 50-69 years as proposed for mammographic screening could result in less striking benefit. Further validation studies should employ a uniform assessment system such as BI-RADS and report not only PPV, but also negative predictive value, sensitivity and specificity. Conclusion: Supplemental breast ultrasound in the population of women with mammographically dense breast tissue (ACR 3 and 4) permits detection of small, otherwise occult, breast cancers. Potential adverse impacts for women in this intermediate risk group are associated with an increased biopsy rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cochrane database of systematic reviews
Geddes, J. (1996) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(96)90063-x · Cited by 5,989
Mammographic Density and the Risk and Detection of Breast Cancer
Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062790 · Cited by 2,478
Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis
McCormack, V. A., & dos Santos Silva, I. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0034 · Cited by 2,143
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Solid breast nodules: use of sonography to distinguish between benign and malignant lesions.
Stavros, A. T., Thickman, D., Rapp, C. L., Dennis, M. A., Parker, S. H., & Sisney, G. A. (1995) · Radiology · doi:10.1148/radiology.196.1.7784555 · Cited by 1,780
Kolb, T. M., Lichy, J., & Newhouse, J. H. (2002) · Radiology · doi:10.1148/radiol.2251011667 · Cited by 1,718
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
The Cochrane Database of Systematic Reviews
Handoll, H. H. (2004) · The British Journal of Hand Therapy · doi:10.1177/175899830400900201 · Cited by 1,513
Berg, W. A., Campassi, C., Langenberg, P., & Sexton, M. J. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.6.1741769 · Cited by 1,273
Elmore, J. G. (2005) · JAMA · doi:10.1001/jama.293.10.1245 · Cited by 1,075
Cited by
Ohuchi, N., Suzuki, A., Sobue, T., Kawai, M., Yamamoto, S., Zheng, Y.-F., Shiono, Y. N., Saito, H., Kuriyama, S., Tohno, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00774-6 · Cited by 616
Identifying Women With Dense Breasts at High Risk for Interval Cancer: A Cohort Study
Kerlikowske, K., Zhu, W., Tosteson, A. N. A., Sprague, B. L., Tice, J. A., Lehman, C. D., Miglioretti, D. L., & for the Breast Cancer Surveillance Consortium* (2015) · Annals of Internal Medicine · doi:10.7326/m14-1465 · Cited by 286
Metadata
- Authors
- Nothacker, M., Duda, V., Hahn, M., Warm, M., Degenhardt, F., Madjar, H., Weinbrenner, S., & Albert, U.-S.
- Venue
- BMC Cancer
- Published
- 2009-09-20
- Volume
- 9
- Issue
- 1
- Pages
- 335-335
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W2017439667
- Cited by
- 314
- References
- 34
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. https://app.cochat.ai/papers/10.1186/1471-2407-9-335
- The paper
- Nothacker, M., Duda, V., Hahn, M., Warm, M., Degenhardt, F., Madjar, H., Weinbrenner, S., & Albert, U.-S. (2009). Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. https://doi.org/10.1186/1471-2407-9-335
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.